TORRENT PHARMA Fact Sheet, TORRENT PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Fact Sheet    (TORR)


EV Stocks: Which is Tanushree's Top Pick?


Here is the latest financial fact sheet of TORRENT PHARMA. For more details, see the TORRENT PHARMA quarterly results and TORRENT PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 2,656.6
Mkt Cap Rs m 449,520
Vol '000 14.5
P/E X 36.9
P/CF X 23.5
EPS (TTM) Rs 72.0
1 Day % 0.2
No. of shares m 169.21
1 Week % -17.2
1 Month % -15.6
1 Year % 0.4
52 week H/L Rs 3,304.5/2,311.3
As on Jan 28, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs1,7681,5501,9642,2863,040 
Low Rs1,1861,1441,2451,4531,933 
Sales per share (Unadj.) Rs341.2351.6453.4469.2473.0 
Earnings per share (Unadj.) Rs55.240.125.860.674.0 
Diluted earnings per shareRs55.240.125.860.674.0 
Cash flow per share (Unadj.) Rs73.364.262.399.2112.9 
Dividends per share (Unadj.) Rs14.0014.0017.0032.0035.00 
Adj. dividends per shareRs14.0014.0017.0032.0035.00 
Avg Dividend yield %0.91.01.11.71.4 
Book value per share (Unadj.) Rs257.1273.1279.2285.0344.9 
Adj. book value per shareRs257.1273.2279.2285.0345.0 
Shares outstanding (eoy) m169.22169.22169.22169.22169.22 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x4.33.83.54.05.3 
Avg P/E ratio x26.833.662.230.933.6 
P/CF ratio (eoy) x20.121.025.818.822.0 
Price / Book Value ratio x5.74.95.76.67.2 
Dividend payout %25.434.965.952.847.3 
Avg Mkt Cap Rs m249,891227,901271,518316,358420,798 
No. of employees `000NANANANANA 
Total wages/salary Rs m9,93411,35314,03814,29014,396 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
TORRENT PHARMA INCOME DATA
Net Sales Rs m57,74559,49876,72879,39380,048 
Other income Rs m2,2332,9886361,213757 
Total revenues Rs m59,97862,48777,36480,60680,806 
Gross profit Rs m13,77313,49316,19521,70424,666 
Depreciation Rs m3,0694,0866,1776,5446,578 
Interest Rs m2,0563,0855,0384,5073,583 
Profit before tax Rs m10,8819,3105,61711,86615,263 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,5452,5291,2541,6192,744 
Profit after tax Rs m9,3366,7814,36310,24712,519 
Gross profit margin %23.922.721.127.330.8 
Effective tax rate %14.227.222.313.618.0 
Net profit margin %16.211.45.712.915.6 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m48,79552,62450,37549,80955,232 
Current liabilities Rs m27,38352,02251,65354,54248,916 
Net working cap to sales %37.11.0-1.7-6.07.9 
Current ratio x1.81.01.00.91.1 
Inventory Days Days7043331614 
Debtors Days Days60776887 
Net fixed assets Rs m45,12787,04987,13585,95681,298 
Share capital Rs m846846846846846 
"Free" reserves Rs m42,65545,37646,39747,38657,526 
Net worth Rs m43,50146,22247,24448,23258,372 
Long term debt Rs m22,40841,11539,12933,03929,633 
Total assets Rs m93,922139,673137,511135,765136,530 
Interest coverage x6.34.02.13.65.3 
Debt to equity ratio x0.50.90.80.70.5 
Sales to assets ratio x0.60.40.60.60.6 
Return on assets %12.17.16.810.911.8 
Return on equity %21.514.79.221.221.4 
Return on capital %19.614.212.320.121.4 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m20,06614,58022,10320,79321,539 
Fx outflow Rs m5,3043,6005,5226,0657,136 
Net fx Rs m14,76210,98016,58114,72714,403 
TORRENT PHARMA CASH FLOW
From Operations Rs m 10,088 8,942 17,981 13,929 20,107 
From Investments Rs m -7,869 -47,070 -2,413 1,986 -4,494 
From Financial Activity Rs m -1,929 34,174 -13,145 -15,490 -16,561 
Net Cashflow Rs m 177 -3,655 2,380 731 -893 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 71.3%
Institution 20.6%
Non-Institution 8.2%
Total 100.0%
Free Float 28.8%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off Torrent House, Off Ashram Road, Ahmedabad - 380009
E-mail investorservices@torrentpharma.com Web www.torrentpharma.com
Tel 079-26599000 Fax 079-26582100
Sector PHARMACEUTICALS Group Torrent Group
Tr Agent K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1972 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 1.3

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare TORRENT PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Views on news

Torrent Pharma Beats Expectations: Stock Gets a Boost (Views On News)

May 19, 2021

Key takeaways from Torrent Pharma's March quarter results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here... (Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022 (Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - PARENT.DRUGS COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS